标题:The association of Crk-like adapter protein with poor prognosis in glioma patients
作者:Yao,C.;Lv,S.;Han,M.;Zhang,J.;Zhang,Y.;Zhang,L.;Yi,R.;Zhuang,D.;Wu,J.
作者机构:[Yao, C] Neurological Surgery Department, Huashan Hospital, Fudan University, 12#, WulumuqiZhong Road, Shanghai 200040, China;[ Lv, S] Department of N 更多
通讯作者:Wu, JS
通讯作者地址:[Wu, JS]Fudan Univ, Shanghai Med Coll, Huashan Hosp, Neurol Surg Dept,Glioma Surg Div, 12 WulumuqiZhong Rd, Shanghai 200040, Peoples R China.
来源:Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine
出版年:2014
卷:35
期:6
页码:5695-5700
DOI:10.1007/s13277-014-1754-y
关键词:CrkL;Glioma;Immunohistochemistry;Prognosis
摘要:Glioma is the most common of brain tumors that greatly affects patient survival. In our precious study, Crk-like adapter protein (CrkL) was identified as a key regulator in glioblastoma development [1]. Here, we aimed to investigate the correlation of CrkL with patient prognosis as well as pathological indicators. Immunohistochemistry was available to evaluate CrkL expression in 49 gliomas of distinct malignancy grade, and positive stained sites were analyzed. CrkL protein was detected in cell lines by Western blot as well. We observed CrkL protein stained in 59.2 % (29 out of 49) of all glioma tissues, including 41.4 % of low-grade (I + II) gliomas, and 85.0 % of high-grade (III + IV) gliomas. Of four grades, grade IV exhibited the highest CrkL level. CrkL protein was also identified in cell lines NHA, U87, U251, T98G, and A172 by Western blot. On the other hand, CrkL expression was significantly associated with the patient\'s age and WHO grade, and patients with high CrkL expression had a significantly shorter median survival time (17 months) than those (median survival time 52 months) with low CrkL expression (p<0.001). According to Cox regression, CrkL can be suggested as an independent prognostic factor. In conclusion, CrkL is differently expressed in different grades of gliomas, and correlated to WHO grade. CrkL also independently indicates poor prognosis in old glioma patients, which can further be recommended as an effective prognostic biomarker or therapeutic target.
收录类别:SCOPUS;SCIE
WOS核心被引频次:4
Scopus被引频次:3
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904767871&doi=10.1007%2fs13277-014-1754-y&partnerID=40&md5=cfba6881bb7401ca2573fffd108c0bb0
TOP